WO2018043911A1 - System for detecting pilot's biometric signal by using wearable continuous body fluid check system - Google Patents

Abstract

The present invention relates to a system for detecting a pilot's biometric signal by using a wearable continuous body fluid check system. The system comprises: a wearable continuous body fluid check system comprising a main control unit which is configured to be wearable by a user, determines whether a blood glucose level, measured by a blood glucose measurement unit for continuously measuring blood glucose levels in a body fluid provided through a body fluid sensor, is out of a normal range, displays a warning through a warning unit when there occurs an abnormal blood glucose condition in which the measured blood glucose level is out of the normal range, and delivers, to a wireless communication interface, whether the abnormal blood glucose condition occurs; and a transportation means system comprising a transportation means control unit which is installed in a transportation means, and receives whether the abnormal blood glucose condition occurs, from the wireless communication interface through a transportation means wireless communication interface via wireless communication.

Description

Pilot Biosignal Detection System Using Wearable Continuous Fluid Check System

The present invention relates to a pilot biosignal detection system using a wearable continuous body fluid check system, which is configured to be worn by a user and is in contact with a probe sensor inserted into the user's skin or body fluid discharged from the user's body surface. Body fluid sensor 110 including any one or more of the surface sensor, a blood glucose measurement unit 120 for continuously measuring the blood glucose value in the body fluid provided through the body fluid sensor 110, and the blood sugar measurement unit ( In operation 120, it is determined whether the blood sugar value is out of a normal range, and when the blood sugar value is out of the normal range, a warning is displayed through a warning unit 150 and the wireless communication interface 160 is displayed. Wearable continuous bodily fluids check system 100 comprising a main control unit 140 for transmitting whether or not the abnormal blood glucose situation; and to the driving means And a driving means control unit 230 configured to receive whether or not the occurrence of the blood glucose abnormality condition from the wireless communication interface 160 by wireless communication through the driving means wireless communication interface 210. ); It relates to a pilot bio-signal detection system 10 using a wearable continuous body fluid check system, characterized in that it comprises a.

In the case of a large means of operation such as an aircraft, a railroad, a bus or a ship, a pilot (usually an engineer / driver in the case of a railroad or a bus or a navigator in the case of a ship) is referred to as a pilot during the operation. Can be placed in a variety of abnormal environments. Sometimes it is necessary to steer a large vehicle such as an aircraft in a rapidly changing environment or an emergency environment, which can cause a drastic change in the pilot's living state. The maintenance status of the aircraft itself is important for the safe operation of the means of operation, but the vital state of the pilot who controls the means of operation is also very important.

In order to measure such a living state of the pilot, the existing prior patent "safety accident prevention device using the aircraft's biological signal or flight pattern (Korea Patent No. 10-1109514)" is installed on the neck support of the cockpit, A pulse sensor for contacting the neck when the pilot is seated to measure the pulse wave of the pilot, a first electrocardiogram sensor installed on the neck support, and contacting the neck when the pilot is seated to measure the first electrocardiogram signal of the pilot; A second electrocardiogram sensor installed in a stick type input device for maneuvering and contacting the hand when the pilot grips the stick type input device by hand to measure a second electrocardiogram signal of the pilot, and the measured pulse wave When the first ECG signal and the second ECG signal are analyzed, and the analysis result determines that the abnormality has occurred in the body of the pilot. Warning signal generator for generating a warning signal there is disclosed a configuration including a.

However, this conventional invention is not enough to be an effective accident prevention precaution because it is most likely that the pilot is out of control since it is judged that such abnormal signs occur because the biological signal of the pilot being measured is merely a pulse / electrocardiogram. There was a problem.

In addition, due to the limitation that the means for measuring the biological signal of the pilot is installed in the neck support of the seat and the stick-type input device, there was a problem that the continuous measurement is not possible due to the change in the attitude of the pilot.

Unlike the above pulse and electrocardiogram, the pilot's biosignal can be predicted to some extent so that precautions can be taken, and there are factors related to the pilot's blood glucose abnormality such as hypoglycemia.

Hypoglycemia refers to a condition in which blood sugar is lower than a normal person. Generally, blood glucose is 50 mg / dl or less. Symptoms include no energy and trembling, paleness, cold sweating, dizziness, excitement, anxiety, and chest palpitations. It may include tingling, fasting, headache, and fatigue. Prolonged hypoglycemia can lead to conditions that are critical to the pilot's condition and operational safety, such as convulsions or seizures and shock conditions that can lead to loss of consciousness. These hypoglycemic symptoms may be caused by various causes such as diabetes or adrenal insufficiency, which are rapidly increasing in recent years. On the other hand, such hypoglycemia can be quickly recovered by taking food (sugar / juice / sugar) that can raise blood sugar quickly, it may be effective to measure by coping with the drop in blood sugar in advance.

In order to continuously measure such blood glucose, a number of continuous glucose monitoring (CGM) systems have recently been proposed. In relation to the existing continuous blood glucose measurement system, Korean Patent No. 10-1512566 or Korean Patent No. 10-1454278 includes a needle inserted into the skin of a user as a sensor capable of continuously monitoring blood glucose levels in the body. Blood glucose measurement sensor based on the nano-structure for improving the sensitivity of the sensor, including the membrane structure is removed interference by using a selective permeability on the surface, the biochemistry can be inserted by means of improving biocompatibility A configuration relating to a continuous glucose monitoring sensor of the type is disclosed.

However, although the configuration disclosed in the existing invention related to the continuous blood glucose measurement system discloses a configuration that is inserted into the user's body and used in the form of a needle, in the case of using a conventional conventional rigid material needle "a" or " b "is inserted into the user's skin directly or obliquely in the direction of the bar, in order to ensure the length of the needle necessary to maintain the required insertion state when the sensor must be worn at all times for continuous blood glucose measurement In this case, there is a problem in that effective blood glucose measurement is impossible because the needle is inserted into the muscle layer (M) through the subcutaneous tissue (S) for a long time to actually measure the blood needle.

In order to solve this problem, when the end of the needle is inserted into a needle with a short length reaching only to the subcutaneous tissue (S), in order to maintain the needle is inserted into the body of the user As well as a new problem that must be fixed by using an external fixing means, there is a problem that it is difficult to always wear and carry to cause a foreign body, pain, etc. to the user.

Meanwhile, another risk factor that may cause a dangerous situation during operation is an increase in blood alcohol concentration due to pilot drinking. Increasing the alcohol concentration by drinking alcohol is extremely dangerous in the operation of all means of operation such as poor judgment and reaction speed, and it is strictly forbidden to fly or operate in the state of high blood alcohol level by law or regulation. It is. However, the measurement of the blood alcohol concentration is most often performed once or selectively, such as by a checkpoint in the case of a flight or a vehicle, and there is a problem in that efficient measurement cannot be continuously performed during operation of the vehicle.

The present invention solves the above-mentioned problems of the present invention, and provides a pilot biosignal detection system using a wearable continuous blood glucose check system that can be easily worn by the pilot, by using the body fluid discharged from the body surface or through invasion The task is to continuously check the pilot's biological signal abnormalities, such as blood sugar or blood alcohol concentration, to detect the occurrence of the abnormal situation in advance and to enable prompt and preventive measures through warnings.

Also, for accurate measurement, the epidermis (E) and dermis (D) of the user's skin are sequentially passed in an oblique direction so that the distal end of the flexible probe sensor is positioned in the subcutaneous (S). Therefore, the object of the present invention is to enable efficient and accurate measurement as well as not to feel foreign objects or pain while maintaining the state inserted in the user's body without a separate external fixing means.

On the other hand, the carbon nanotube (CNT) hybrid sensor electrode in which boron doped diamond (BDD) is fixed to the surface for more accurate measurement can be measured more precisely even with a shallow depth of infiltration. As a matter of course, it is a task to be able to increase the user's convenience.

In order to achieve the above object, the pilot biosignal detection system using a wearable continuous body fluid check system according to an embodiment of the present invention is configured to be worn by the user, a probe sensor that is partially inserted into the user's skin or Blood glucose measurement for continuously measuring the blood glucose value in the body fluid sensor 110 and any body fluid provided through the body fluid sensor 110, including any one or more of the surface sensor in contact with the body fluid discharged from the body surface of the user The unit 120 determines whether the blood sugar value measured by the blood sugar measurement unit 120 is outside the normal range, and when the blood sugar value is out of the normal range, the warning unit 150. Wearable continuous configured to include a main control unit 140 for displaying a warning through the wireless communication interface 160 to communicate whether or not the blood glucose abnormal situation Liquid check system 100; and a driving means control unit which is installed in the driving means and receives whether or not the blood glucose abnormality occurs from the wireless communication interface 160 by wireless communication through the driving means wireless communication interface 210 ( A vehicle means system 200 configured to include 230; Characterized in that comprises a.

In addition, the wearable continuous body fluid check system 100, the body alcohol concentration measurement unit 130 for continuously measuring the blood alcohol concentration in the body fluid provided through the body fluid sensor 110; The main controller 140 displays a warning through the warning unit 150 when it is determined that the blood alcohol concentration measured by the body alcohol concentration measuring unit 130 is equal to or higher than an alcohol concentration. Characterized in that it is further delivered whether or not the alcohol concentration is higher than 160).

In addition, the wearable continuous bodily fluid check system 100 further includes any one or more of an electrocardiogram sensor 170 capable of measuring an electrocardiogram of the user or a pulse sensor 180 measuring the heartbeat vibration of the user. The main controller 140 is configured to analyze the ECG signal or the pulse signal measured by the ECG sensor 170 or the pulse sensor 180, and when it is determined that the ECG or heart rate is abnormal, the warning unit 150. By displaying a warning through the) and the ECG or heart rate abnormality is further characterized in that the wireless communication interface (160).

In addition, the driving means system 200, the driving means communication unit 220 for transmitting whether the abnormal situation received from the driving means control unit 230 to the control server 300 through a communication network; Characterized in that further comprises.

In addition, the vehicle means system 200, when the abnormal situation occurs in accordance with the control of the vehicle control unit 230 automatically stops the operation of the automatic control device 240 or the vehicle means for automatically controlling the vehicle means It characterized in that it further comprises any one of the emergency driving device 250 to.

On the other hand, the bodily fluid sensor 110 is composed of a flexible probe sensor made of a material having an elastic, the flexible probe sensor is in the oblique direction of the epidermis (E), dermis (D) of the skin of the user It is characterized in that it is configured so that the end portion is positioned in the subcutaneous tissue (Subcutaneous) (S) sequentially, the flexible probe sensor is curved with a predetermined curvature toward the outside direction when inserted into the user's skin It is characterized by being molded to have.

In addition, the bodily fluid sensor 110 is composed of a carbon nanotube (CNT) hybrid sensor electrode on which boron doped diamond (BDD) 111 is fixed to a surface thereof. The carbon nanotube (CNT) hybrid sensor electrode in which the boron-doped diamond (BDD) is fixed to the surface of the boron-doped diamond (BDD) is infiltrated into the skin of the user at a depth of 2 to 5 mm. It features.

The present invention solves the above-mentioned problems of the present invention, and provides a pilot biosignal detection system using a wearable continuous blood glucose check system that can be easily worn by the pilot, by using the body fluid discharged from the body surface or through invasion By continuously checking the abnormality of the pilot's biological signal, such as blood sugar or blood alcohol concentration, it is possible to detect the occurrence of the abnormal situation in advance and to quickly and preventively cope with the warning.

Also, for accurate measurement, the epidermis (E) and dermis (D) of the user's skin are sequentially passed in an oblique direction so that the distal end of the flexible probe sensor is positioned in the subcutaneous (S). As a result, efficient and accurate measurement is possible, as well as it is possible not to feel foreign bodies or pain while maintaining the state inserted into the user's body without a separate external fixing means.

On the other hand, the carbon nanotube (CNT) hybrid sensor electrode in which boron doped diamond (BDD) is fixed to the surface for more accurate measurement can be measured more precisely even with a shallow depth of infiltration. Of course, there is an advantage that it is possible to increase the convenience of the user.

1 is a block diagram showing the configuration of a pilot biosignal detection system using a wearable continuous fluid check system according to an embodiment of the present invention.

2 is a view showing an invasive state of the flexible probe sensor of the pilot biosignal detection system using the wearable continuous fluid check system according to an embodiment of the present invention.

Figure 3: Carbon nanotubes (CNT: Carbon Nanotubes) in which boron doped diamond (BDD) of a pilot biosignal detection system using a wearable continuous fluid check system according to an embodiment of the present invention is fixed to a surface Tube) A diagram showing the configuration of a hybrid sensor electrode.

4: Carbon nanotubes (BNT: Boron Doped Diamond) of a pilot biosignal detection system using a wearable continuous fluid check system according to an embodiment of the present invention is fixed on the surface (CNT: Carbon Nano) Tube) Electron micrograph showing the configuration of a hybrid sensor electrode.

FIG. 5: Carbon nanotubes (BNT: Boron Doped Diamond) of a pilot biosignal detection system using a wearable continuous body fluid check system according to an embodiment of the present invention settled on a surface Tube) A more magnified electron micrograph showing the composition of the hybrid sensor electrode.

[Description of Symbols Used in Drawings]

10: Pilot biosignal detection system using wearable continuous fluid check system

100: wearable continuous fluid check system

110: fluid sensor

120: blood glucose measurement unit

130: blood alcohol concentration measurement unit

140: subject fisherman

150: warning

160: wireless communication interface

170: ECG sensor

180: pulse sensor

200: vehicle system

210: driving means wireless communication interface

220: driving means communication unit

230: means of transportation

240: autopilot

250: emergency driving device

300: control server

Hereinafter, with reference to the accompanying drawings, a pilot biosignal detection system using a wearable continuous fluid check system according to an embodiment of the present invention will be described in detail. First, in the drawings, the same components or parts are to be noted that as indicated by the same reference numerals as possible. In describing the present invention, detailed descriptions of related well-known functions or configurations are omitted in order not to obscure the subject matter of the present invention.

Pilot bio-signal detection system using the wearable continuous body fluid check system of the present invention, as shown in Figure 1, wearable continuous body fluid check system 100 worn by the user, and is mounted on a vehicle, train, bus, etc. It characterized in that it comprises a vehicle means system 200.

First, the wearable continuous bodily fluid check system 100 will be described. The wearable continuous bodily fluid check system 100 is configured to be worn by a user including the pilot in the form of a small portable device or a smart watch and the like, as shown in FIG. A blood glucose value is measured in the bodily fluid sensor 110 including at least one of a partially inserted probe sensor or a surface sensor contacting the bodily fluid discharged from the user's body surface, and the bodily fluid provided through the bodily fluid sensor 110. It is configured to include a blood glucose measurement unit 120 to measure continuously. In this case, the blood glucose measurement unit 120 uses the body fluid of the user provided through the bodily fluid sensor 110 to fix the reversible glucose antibody on the surface, thereby combining the reversible glucose antibody and the glucose molecule in the body fluid. And an unmarked sensor for detecting a signal generated. Including the non-labeled sensor, a number of prior art documents including the Republic of Korea Patent No. 10-1512566 or Republic of Korea Patent No. 10-1454278 regarding the configuration and operation principle of the continuous blood glucose measurement sensor unit 100 Since it is described in detail, detailed description is omitted. On the other hand, when the body fluid sensor 110 is configured to include the surface sensor in contact with the body fluid discharged from the body surface of the user, the body fluid of the user in contact may include sweat or tears. In this case, the surface sensor is preferably installed to be attached or contacted to the body part of the user that is easy to contact the body fluids such as sweat or tears. That is, it is possible to attach in the form of a separate sensor patch, of course, when the wearable continuous body fluid check system 100 is worn in the form of a portable device or a smart watch, such as close to the user's body surface Alternatively, it may be installed in the contact portion.

On the other hand, when the body fluid sensor 110 is composed of a probe sensor which is partially inserted into the user's skin, the body fluid sensor 110 is preferably a flexible probe sensor made of a material having elasticity. In this case, the flexible probe sensor 110 is a measurement target for blood glucose measurement by sequentially passing through the epidermis (E), the dermis (Dermis) (D) of the user's skin in an oblique direction as shown in FIG. It is characterized in that the end portion is located in the subcutaneous tissue (Subcutaneous) (S) where the capillaries through which blood is circulated are well distributed. That is, when the flexible probe sensor 110 is made of a flexible material having elasticity, when the flexible probe sensor 110 is slowly inserted into the user's skin in an oblique direction, the epidermis (E), The flexible probe sensor 110 can be inserted in the form of a gentle curve as shown in FIG. 2 depending on the characteristics of the dermis (D) and the strength and tissue composition of the subcutaneous tissue.

As described above, in order to further ensure that the flexible probe sensor 110 is inserted with a gentle curve such as a dotted line indicated by "c" in FIG. 2, the flexible probe sensor 110 may be inserted into the skin of the user. When inserted into the mold, it is preferable to be molded to have a curved shape with a predetermined curvature toward the outer direction as shown in FIG. 2. This configuration has the advantage that it is possible to feel no foreign body or pain while maintaining the state inserted into the user's body without a separate external fixing means.

Meanwhile, in another embodiment in which the body fluid sensor 110 is configured as a probe sensor, the body fluid sensor 110 has a boron doped diamond (BDD) 111 as shown in FIG. 3. The carbon nanotube (CNT) 112 is preferably composed of a hybrid sensor electrode.

Diamond, a group 4 semiconductor element such as silicon, is an ultra-fast device material with a charge transfer rate of three times that of silicon and 4.5 times that of GaAs (gallium arsenide), and is the basic impedance of a sensor electrode made of gold or platinum. ), But the impedance of the carbon nanotube (CNT) hybrid sensor electrode structure in which boron doped diamond (BDD) 111 is fixed to the surface is several Ω. Is nothing. Therefore, it has extremely sensitive and efficient detection characteristics.

On the other hand, it has a much larger effective electrode area as shown in Table 1 than conventional carbon nanotube (CNT) single material sensors or boron doped diamond (BDD) sensors. With this, very good sensitivity and measurement limits are shown, as shown at the bottom in Table 2.

Electrode	Correlation coefficient (R)	Randle`s slope	Effective electrode area (㎠)
CNT	0.9953	0.0608	0.259
BDD	0.9981	0.1633	0.696
BDD-CNT	0.9971	0.5060	2.130
CNT: carbon nanotubeBDD: boron-doped diamondBDD-CNT: boron-doped diamond carbon nanotube

Electrode	Linear range	sensitivity	Correalation coefficient (R)	Detection limit (μM)
CNT	563 ~ 56.25	0.215	0.9974	564
BDD	0.00000289-0.000188	13.278	0.9917	0.00072
BDD-CNT	0.000000654-0.00008375	8720.072	0.9932	0.00004
CNT: carbon nanotubeBDD: boron-doped diamondBDD-CNT: boron-doped diamond carbon nanotube

In addition, as shown in the bottom of Table 3 has a superior sensitivity and measurement limits compared to the existing electrodes of various other materials.

Electrode	Linear range (mM)	Sensitivity	Detection limit
Glucose Oxidase / Silver nanoparticles / Chitosan / ITO	0.0005-0.05	136	0.1
Glucose Oxidase / Zinc oxide nanofibers / Au	0.25-19	70.2	1.0
Glucose Oxidase / Gold core silver shell nanorods / GCE	0.02 ~ 7.02	34.29	0.67
Glucose Oxidase / Platinum nanoparticles / PAni / Pt	0.01-8	96.1	0.7
Glucose Oxidase / Bovine serum albumin-glutaraldehyde / Titanium oxide nanotubes / Ti	0.05 ~ 0.65	199.6	3.8
Glucose Oxidase / boron-doped diamond carbon nanotube / SiO₂	0.000000654-0.00008375	3841.78	0.00004

The carbon nanotube hybrid sensor electrode in which the boron-doped diamond (BDD) is settled on the surface is fast and accurate due to high sensitivity and minimized minimum detection limit as described above. Since the measurement is possible, sufficient measurement is possible even if only the depth of about 2 to 5 mm is invaded from the existing 10 mm or more to the depth of the user's skin. In addition, by reducing the depth of invasion, you can expect a fast response time and a short settling time due to the reduction of the capillary length of the probe sensor, of course, due to the sensitivity of tens of thousands of conventional sensors despite the short sensing time More accurate measurements are possible.

Next, the main control unit 140 will be described. As shown in FIG. 1, the main controller 140 is connected to the blood sugar measuring unit 120 to determine whether the blood sugar value measured by the blood sugar measuring unit 120 is out of a normal range, and the blood sugar level is determined. If the value is a blood glucose abnormal situation out of the normal range performs a function to display a warning through the warning unit 150. When the warning is displayed through the warning unit 150 as described above, the user (pilot) may perform a proper response in advance, such as ingesting foods that can supplement blood glucose, and thus, according to the hypoglycemic state Dangerous situations such as convulsions, seizures and shock can lead to loss of consciousness.

Meanwhile, as shown in FIG. 1, the main controller 140 is configured to enable wireless communication according to a general short-range wireless communication standard such as Wi-Fi or Bluetooth. ), And also transmits the blood glucose abnormality status to the wireless communication interface (160). That is, the user is in a state of boarding the driving means equipped with a driving means system 200, which will be described later, the driving means does not use a conventional wireless communication network according to its characteristics, a special communication network (for example, airspace) It is often used for aircraft flying in the sea or for ships operating on the high seas. In addition, even in the case of land running means which can use a conventional communication network, wireless communication is often difficult to be performed smoothly according to the movement speed or the environment of the movement position. Accordingly, the wearable continuous body fluid check system 100 which is manufactured to be relatively small to be worn is sufficiently capable of communicating smoothly even with a weak radio wave strength with the driving means system 200 mounted on the traveling means moving together. Efficient communication is possible only by having the wireless communication interface 160, and wireless communication with the control server 300, etc., which is located outside, is to use the driving means communication unit 230 installed in the driving means as will be described later. It is desirable to.

On the other hand, by using the characteristics that can be used to measure the user's body fluids steadily and continuously through the body fluid sensor 110, so that it is possible to measure the blood alcohol concentration of the user fatal to safety while driving, the wearable As shown in FIG. 1, the continuous bodily fluid check system 100 further includes an internal alcohol concentration measuring unit 130 that continuously measures blood alcohol concentration in the bodily fluid provided through the bodily fluid sensor 110. desirable.

In this case, the main control unit 140 displays a warning through the warning unit 150 when it is determined that the blood alcohol concentration measured by the body alcohol concentration measuring unit 130 is an alcohol concentration or higher than a reference value and wirelessly. It is preferable to further communicate whether the alcohol concentration is abnormal to the communication interface 160. On the other hand, in the practical operation of the pilot bio-signal detection system 10 using the wearable continuous fluid check system of the present invention, wearing the pilot blood alcohol concentration check function using the wearable continuous fluid check system 100, The type continuous fluid check system 100 is mandatory for all pilots to carry out the pre-flight drinking test, which is currently performed only on a randomly selected personnel, at the moment. In addition, it can also play an important role in preventing drunk aircraft's drinking behavior during flight.

On the other hand, the pilot bio-signal detection system using the wearable continuous fluid check system of the present invention, as shown in Figure 1 to measure the electrocardiogram or heart rate of the pilot, ECG sensor 170 that can measure the ECG of the user Or any one or more of the pulse sensor 180 for measuring the heartbeat vibration of the user, wherein the main control unit 140 is the electrocardiogram measured by the ECG sensor 170 or the pulse sensor 180 Analyzing the signal or pulse signal, if it is determined that the ECG or cardiac abnormal situation, it is preferable to display a warning through the warning unit 150 and to further transmit whether the ECG or heart rate abnormal situation to the wireless communication interface 160. Do.

The ECG sensor 170 is composed of two or more electrodes that can be in contact with the pilot's skin. ECG is an abbreviation of ECG (ElectroCardioGram), and the excitation of myocardium that arises from the sinus and goes to the atrial / ventricular direction is described as a graph of the active current of the heart obtained by inducing an ammeter (electrocardiograph) at two arbitrary points of the human body. Can be. Electrocardiogram obtained in this way is very important data for diagnosis of heart disease, coronary artery disease such as angina pectoris and myocardial infarction, diagnosis of various arrhythmia and electrolyte abnormalities, or investigation of heart abnormalities during surgery. It can be used as. In this case, when the wearable continuous body fluid check system 100 is configured in the form of a smart watch, the ECG sensor 170 may be installed under the main body of the smart watch.

The pulsation sensor 180 may contact the body of the pilot, detect vibration of the pilot's heartbeat, and convert the vibration signal into an electrical signal. Pulse wave refers to the waveform of changes in the pressure and volume of the vascular system and valves based on physical changes in the heart. To this end, the pulse sensor 180 may be implemented as a kind of transducer means for detecting the pulse wave vibration and converting it into an electrical signal. On the other hand, when the wearable continuous body fluid check system 100 is configured in the form of a smart watch (Smart Watch), it is worn on the wrist portion that can efficiently measure the pulse of the pilot so that the pulse sensor 180 Efficient measurement is possible.

Next, the vehicle means system 200 will be described. The vehicle means system 200 is installed in the vehicle, as shown in FIG. 1, the blood sugar abnormality situation, alcohol concentration from the wireless communication interface 160 by wireless communication through the vehicle means wireless communication interface 210 It is configured to include a driving means control unit 230 that receives whether the abnormal situation, electrocardiogram or heart rate abnormal situation occurs.

On the other hand, when the above-mentioned abnormal situation occurs, the vehicle means system 200, to enable immediate delivery to the control authority, whether the abnormal situation received from the vehicle control unit 230 to the control server 300 through the communication network It is preferable that the transmission means further comprises a communication unit 220 for transmission. In this case, the driving means communication unit 220, as described above, the communication standard used for communication between the moving means and the control engine in motion (for example, the air traffic control communication used for air communication when the driving means is an aircraft) (ATC), aeronautical operations management communications (AOC), aeronautical services communications (AAC), aeronautical aerial communications (APC)).

In addition, the driving means system 200, under the control of the driving means control unit 230 when the abnormal situation occurs as shown in FIG. Autopilot 240 for automatically controlling the driving means (for example, in the case of aircraft, auto-pilot (Auto-Pilot) device, etc.) or emergency driving device 250 for safely stopping the operation of the driving means ( For example, in the case of a train, it is preferable that the vehicle further includes any one of an automatic stop device / a vehicle, such as a device that does not start the vehicle in a state before departure.

In the foregoing description, optimal embodiments have been disclosed in the drawings and the specification. Although specific terms have been used herein, they are used only for the purpose of describing the present invention and are not used to limit the scope of the present invention as defined in the meaning or claims. Therefore, those skilled in the art will understand that various modifications and equivalent other embodiments are possible. Therefore, the true technical protection scope of the present invention will be defined by the technical spirit of the appended claims.

Claims (7)

1. A bodily fluid sensor 110 configured to be worn by a user and including at least one of a probe sensor partially inserted into a user's skin or a surface sensor contacting a bodily fluid discharged from a user's body surface, and the bodily fluid The blood sugar measuring unit 120 continuously measuring the blood sugar value in the body fluid provided through the sensor 110, and determines whether the blood sugar value measured by the blood sugar measuring unit 120 is outside the normal range, If the blood sugar value is out of the normal range of the blood sugar abnormality situation to display a warning through the warning unit 150 and the main communication unit 140 including a main control unit for transmitting the status of the blood sugar abnormality to the wireless communication interface 160 Type continuous fluid check system 100;

   The driving means is installed in the driving means, and includes a driving means control unit 230 that receives whether or not the occurrence of the blood glucose abnormality situation from the wireless communication interface 160 by wireless communication through the driving means wireless communication interface 210. System 200; Pilot bio-signal detection system using a wearable continuous fluid check system, characterized in that it comprises a.
2. The method according to claim 1,

   The wearable continuous body fluid check system 100, the body alcohol concentration measurement unit 130 for continuously measuring the blood alcohol concentration in the body fluid provided through the body fluid sensor 110;

   The main controller 140 displays a warning through the warning unit 150 when it is determined that the blood alcohol concentration measured by the body alcohol concentration measuring unit 130 is equal to or higher than an alcohol concentration. Pilot bio-signal detection system (10) using the wearable continuous body fluid check system, characterized in that further conveying whether or not the alcohol concentration abnormal situation.
3. The method according to claim 1,

   The wearable continuous fluid check system 100,

   It further comprises any one or more of the electrocardiogram sensor 170 for measuring the electrocardiogram of the user or the pulse sensor 180 for measuring the heart rate vibration of the user,

   The main controller 140 analyzes the electrocardiogram signal or the pulse signal measured by the electrocardiogram sensor 170 or the pulse wave sensor 180, and determines that the electrocardiogram or the heartbeat abnormality is detected through the warning unit 150. Pilot bio-signal detection system (10) using a wearable continuous body fluid check system characterized in that it displays a warning and further communicates whether the ECG or heart rate abnormality situation to the wireless communication interface (160).
4. The method according to any one of claims 1 to 3,

   The vehicle means system 200,

   A driving means communication unit 220 which transmits whether the abnormal situation received from the driving means control unit 230 is transmitted to the control server 300 through a communication network; Pilot bio-signal detection system using a wearable continuous body fluid check system, characterized in that it further comprises a (10).
5. The method according to claim 4,

   The vehicle means system 200,

   When the abnormal situation occurs, either the automatic steering device 240 for automatically controlling the driving means under the control of the driving means control unit 230 or the emergency driving device 250 for safely stopping the operation of the driving means. Pilot bio-signal detection system using a wearable continuous fluid check system, characterized in that further comprises.
6. The method according to claim 1,

   The body fluid sensor 110 is composed of a flexible probe sensor made of a material having elasticity as a probe sensor,

   The flexible probe sensor is configured to pass through the epidermis (E), the dermis (Dermis) (D) of the user's skin sequentially in the oblique direction, the end portion is located in the subcutaneous (S). With

   When the flexible probe sensor is inserted into the user's skin, the pilot biological signal detection system using a wearable continuous body fluid check system, characterized in that it is molded to have a curved shape with a predetermined curvature toward the outside direction.
7. The method according to claim 1,

   The body fluid sensor 110 is composed of a carbon nanotube (CNT) hybrid sensor electrode in which boron doped diamond (BDD) 111 is fixed to a surface as a probe sensor. Features,

   Carbon nano tube (CNT) hybrid sensor electrode in which the boron-doped diamond (BDD) is fixed to the surface is infiltrated into the skin of the user at a depth of 2 to 5 mm. Pilot biosignal detection system (10) using a wearable continuous fluid check system.

Images